Skip to main content
Earnings Labs
Organogenesis Holdings Inc. logo

Organogenesis Holdings Inc. (ORGO)

NASDAQ·Healthcare·Drug Manufacturers - Specialty & Generic

$2.38

-1.25%

Mkt Cap $310.11M

Analyst Ratings

Buy

3

Hold

0

Sell

0

Price Target (3 analysts)

$6.67

Range $5.00$9.00

Implied Upside

+180.8%

Consensus $6.67 vs current $2.38